About
Radio Optimized Vector Engineering platform
Areas of Focus
Categories
Biologics & BiopharmaceuticalRadiopharmaceuticalsAntibody
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
110
By Phase
EARLY_PHASE1: 1PHASE1: 1
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07052760Collaborator
Imaging of Solid Tumors Using DLL3 SPECT
EARLY_PHASE1Not yet recruiting
45 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2027
NCT06736418Lead Sponsor
Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy
PHASE1Recruiting
65 participants
Started: Mar 10, 2025 · Completed: Jan 31, 2027
Locations (1)
Headquarters
Vancouver, BC, Canada
Map
Loading map...